NovaBay Pharmaceuticals, Inc. (NYSEAMERICAN:NBY) Sees Significant Decrease in Short Interest
NovaBay Pharmaceuticals, Inc. (NYSEAMERICAN:NBY – Get Free Report) was the target of a significant drop in short interest in February. As of February 28th, there was short interest totalling 89,000 shares, a drop of 19.2% from the February 13th total of 110,200 shares. Currently, 2.1% of the shares of the stock are short sold. Based […]
NovaBay Pharmaceuticals, Inc. (NYSEAMERICAN:NBY – Get Free Report) was the target of a significant drop in short interest in February. As of February 28th, there was short interest totalling 89,000 shares, a drop of 19.2% from the February 13th total of 110,200 shares. Currently, 2.1% of the shares of the stock are short sold. Based […]
